16725

    532983

    RPGLIFE

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    RPG LIFE SCIENCES LTD Share Price Today

    RPG LIFE SCIENCES LTD is currently trading at ₹2450, up by ₹34.19 from the previous close. The stock touched an intraday high of ₹2479.20 and a low of ₹2385.80 during the latest trading session. Over the past one year, RPG LIFE SCIENCES LTD has delivered a loss of 3.45%, while the stock has gained 9.89% in the last one month.

    RPG LIFE SCIENCES LTD performance

    Today’s low Today’s high
    ₹ 2385.80 ₹ 2479.20
    ₹ 2416.50
    52 week low 52 week high
    ₹ 1733.00 ₹ 2725.00
    ₹ 2416.50
    Open Price ₹ 2415.80
    Prev. Close ₹ 2415.80
    Volume (Shares) 6784.00
    Total traded value ₹ 163.93
    Upper Circuit ₹ 2898.90
    Lower Circuit ₹ 1932.70
    info

    Investment Returns

    Over 1 Month 9.89% Over 3 Months 27.11% Over 6 Months 4.54% Over 1 Year -3.45%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    RPG LIFE SCIENCES LTD fundamentals


    • Market cap (Cr) 3,996.70
    • P/E Ratio (TTM) 34.70
    • Beta 0.83
    • Book Value / share 366.02
    • Return on equity 20.28%
    • EPS (TTM) 66.31
    • Dividend yield 0.99%
    • Net profit/quarter (Cr) 29.90
    info icon alternate text
    • Market cap (Cr) 3,979.30
    • P/E Ratio (TTM) 34.70
    • Beta 0.75
    • Book Value / share 366.02
    • Return on equity 20.28%
    • EPS (TTM) 66.31
    • Dividend yield 0.99%
    • Net profit/quarter (Cr) 29.90
    info icon alternate text

    RPG LIFE SCIENCES LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 176.89
    Operating Expense 150.14
    Net Profit 29.90
    Net Profit Margin (%) 16.90
    Earnings Per Share (EPS) 18.08
    EBITDA 46.33
    Effective Tax Rate (%) 25.62
    Particulars DEC 2025 (Values in Cr)
    Revenue 180.03
    Operating Expense 145.90
    Net Profit 22.13
    Net Profit Margin (%) 12.29
    Earnings Per Share (EPS) 13.38
    EBITDA 34.75
    Effective Tax Rate (%) 24.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 181.68
    Operating Expense 147.99
    Net Profit 36.85
    Net Profit Margin (%) 20.28
    Earnings Per Share (EPS) 22.28
    EBITDA 54.79
    Effective Tax Rate (%) 25.48
    Particulars JUN 2025 (Values in Cr)
    Revenue 168.92
    Operating Expense 138.72
    Net Profit 26.29
    Net Profit Margin (%) 15.56
    Earnings Per Share (EPS) 15.90
    EBITDA 40.70
    Effective Tax Rate (%) 25.79
    Particulars MAR 2025 (Values in Cr)
    Revenue 143.09
    Operating Expense 123.15
    Net Profit 117.35
    Net Profit Margin (%) 82.01
    Earnings Per Share (EPS) 70.96
    EBITDA 140.45
    Effective Tax Rate (%) 13.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 707.52
    Operating Expense 582.76
    Net Profit 115.17
    Net Profit Margin (%) 16.27
    Earnings Per Share (EPS) 69.64
    EBITDA 176.56
    Effective Tax Rate (%) 25.31
    Particulars MAR 2025 (Values in Cr)
    Revenue 653.43
    Operating Expense 515.83
    Net Profit 183.24
    Net Profit Margin (%) 28.04
    Earnings Per Share (EPS) 110.80
    EBITDA 254.93
    Effective Tax Rate (%) 21.31
    Particulars MAR 2024 (Values in Cr)
    Revenue 582.05
    Operating Expense 471.42
    Net Profit 87.66
    Net Profit Margin (%) 15.06
    Earnings Per Share (EPS) 53.01
    EBITDA 135.36
    Effective Tax Rate (%) 25.61
    Particulars MAR 2023 (Values in Cr)
    Revenue 512.81
    Operating Expense 425.93
    Net Profit 67.64
    Net Profit Margin (%) 13.19
    Earnings Per Share (EPS) 40.90
    EBITDA 107.49
    Effective Tax Rate (%) 26.22
    Particulars MAR 2022 (Values in Cr)
    Revenue 440.16
    Operating Expense 369.97
    Net Profit 51.48
    Net Profit Margin (%) 11.69
    Earnings Per Share (EPS) 31.13
    EBITDA 89.35
    Effective Tax Rate (%) 29.64
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 366.05
    ROE % 20.28
    ROCE % 26.57
    Total Debt to Total Equity 0.02
    EBITDA Margin 25.08
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 320.80
    ROE % 21.79
    ROCE % 27.60
    Total Debt to Total Equity 0.00
    EBITDA Margin 26.00
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 366.06
    ROE % 20.28
    ROCE % 26.57
    Total Debt to Total Equity 0.02
    EBITDA Margin 25.08
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 320.80
    ROE % 25.53
    ROCE % 32.28
    Total Debt to Total Equity 0.00
    EBITDA Margin 26.00
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 226.67
    ROE % 25.69
    ROCE % 34.25
    Total Debt to Total Equity 0.00
    EBITDA Margin 23.43
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 186.00
    ROE % 24.01
    ROCE % 32.15
    Total Debt to Total Equity 0.00
    EBITDA Margin 21.12
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 154.66
    ROE % 21.80
    ROCE % 30.57
    Total Debt to Total Equity 0.01
    EBITDA Margin 20.50
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 191.56
    Total Assets 793.16
    Total Liabilities 793.16
    Total Equity 605.35
    Share Outstanding 1
    Price to Book Ratio 5.05
    Return on Assets (%) 14.52
    Return on Capital (%) 18.42
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 139.61
    Total Assets 657.81
    Total Liabilities 657.81
    Total Equity 530.53
    Share Outstanding 1
    Price to Book Ratio 7.10
    Return on Assets (%) 27.85
    Return on Capital (%) 34.54
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 156.78
    Total Assets 793.14
    Total Liabilities 793.14
    Total Equity 605.37
    Share Outstanding 1
    Price to Book Ratio 5.05
    Return on Assets (%) 14.52
    Return on Capital (%) 18.42
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 139.61
    Total Assets 657.81
    Total Liabilities 657.81
    Total Equity 530.53
    Share Outstanding 1
    Price to Book Ratio 7.10
    Return on Assets (%) 27.85
    Return on Capital (%) 34.54
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 36.47
    Total Assets 512.87
    Total Liabilities 512.87
    Total Equity 374.85
    Share Outstanding 1
    Price to Book Ratio 6.75
    Return on Assets (%) 17.09
    Return on Capital (%) 23.39
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 57.04
    Total Assets 419.35
    Total Liabilities 419.35
    Total Equity 307.60
    Share Outstanding 1
    Price to Book Ratio 3.74
    Return on Assets (%) 16.12
    Return on Capital (%) 21.99
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 70.26
    Total Assets 344.61
    Total Liabilities 344.61
    Total Equity 255.77
    Share Outstanding 1
    Price to Book Ratio 3.62
    Return on Assets (%) 14.93
    Return on Capital (%) 20.1
    Particulars MAR 2026 (Values in Cr)
    Net Income 154.20
    Cash from Operations 93.72
    Cash from Investing 85.84
    Cash from Financing -20.58
    Net change in Cash 121.76
    Free Cash Flow 159.07
    Particulars MAR 2025 (Values in Cr)
    Net Income 232.88
    Cash from Operations 130.61
    Cash from Investing -41.80
    Cash from Financing -27.08
    Net change in Cash 8.98
    Free Cash Flow 166.64
    Particulars MAR 2026 (Values in Cr)
    Net Income 154.20
    Cash from Operations 93.71
    Cash from Investing 51.06
    Cash from Financing -20.58
    Net change in Cash 86.98
    Free Cash Flow 159.07
    Particulars MAR 2025 (Values in Cr)
    Net Income 232.88
    Cash from Operations 130.61
    Cash from Investing -41.80
    Cash from Financing -27.08
    Net change in Cash 8.98
    Free Cash Flow 166.64
    Particulars MAR 2024 (Values in Cr)
    Net Income 117.84
    Cash from Operations 123.67
    Cash from Investing -79.15
    Cash from Financing -20.31
    Net change in Cash -5.10
    Free Cash Flow 192.90
    Particulars MAR 2023 (Values in Cr)
    Net Income 91.68
    Cash from Operations 116.05
    Cash from Investing -105.81
    Cash from Financing -17.12
    Net change in Cash -32.11
    Free Cash Flow 148.78
    Particulars MAR 2022 (Values in Cr)
    Net Income 73.17
    Cash from Operations 83.60
    Cash from Investing -34.66
    Cash from Financing -13.51
    Net change in Cash 16.58
    Free Cash Flow 107.55
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 13.52 1.58 250.74 23.12 38.85
    BLISS GVS PHARMA LTD 506.15 40.69 4.49 5368.04 118.35 552.90
    CIPLA LTD 1458.45 30.95 3.42 117820.20 1165.55 1672.20
    FERMENTA BIOTECH LTD. 345.85 15.26 2.50 1017.87 256.40 399.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 22.88 4.21 250.74 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 536.85 24.06 4.19 1552.07 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8297.90 108.37 23.76 20744.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 506.15 54.72 4.64 5368.04 118.35 552.90

    RPG LIFE SCIENCES LTD shareholding pattern

    Holding
    18.72%
    72.95%
    0.87%
    7.44%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    RPG LIFE SCIENCES LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    2416.50 0.02 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 2362.90
    • 26 Days 2277.40
    • 10 Days 2329.50
    • 50 Days 2225.80
    • 12 Days 2319.90
    • 100 Days 2179.20
    • 20 Days 2292.60
    • 200 Days 2182.70
    2428.97 PIVOT
    First Support 2382.93 First Resistance 2461.83 Second Support 2350.07 Second Resistance 2507.87 Third Support 2304.03 Third Resistance 2540.73
    RSI 67.69 ADX 19.21 MACD 42.47 Williams % R -22.93 Commodity Channel Index (CCI) 156.93
    Date 2026-07-03 Week 5787.00 Same Day 2493.00 Month 5174.00
    1 Year 0.84 3 Year 0.78
    Over 1 Month
    9.89% down
    Over 1 Year
    -3.45% down
    Over 3 Months
    27.11% down
    Over 3 Years
    37.69% down
    Over 6 Months
    4.54% down
    Over 5 Years
    40.14% down

    RPG LIFE SCIENCES LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    09 Jul 2026 24.0 Final 09 Jul 2026 Equity shares
    27 Jun 2025 4.0 Special 27 Jun 2025 Equity shares
    27 Jun 2025 20.0 Final 27 Jun 2025 Equity shares
    28 Jun 2024 16.0 Final 28 Jun 2024 Equity shares
    21 Jul 2023 12.0 Final 21 Jul 2023 Equity shares
    14 Jul 2022 9.6 Final 15 Jul 2022 Equity shares
    13 Aug 2021 7.2 Final 17 Aug 2021 Equity shares
    24 Mar 2020 4.0 Interim 26 Mar 2020 Equity shares
    22 Jul 2019 2.4 Final 24 Jul 2019 Equity shares
    19 Jul 2018 2.4 Final 21 Jul 2018 Equity shares
    13 Jul 2017 2.8 Final 17 Jul 2017 Equity shares
    22 Mar 2016 1.6 Interim 24 Mar 2016 Equity shares
    20 Jul 2015 0.8 Final 22 Jul 2015 Equity shares
    11 Sep 2014 0.8 Special 15 Sep 2014 Equity shares
    11 Sep 2014 1.2 Final 15 Sep 2014 Equity shares
    11 Jul 2013 1.2 Final 15 Jul 2013 Equity shares
    24 Jul 2012 0.8 Final 26 Jul 2012 Equity shares
    14 Jul 2011 1.6 Final 18 Jul 2011 Equity shares
    15 Jul 2010 1.44 Final 19 Jul 2010 Equity shares
    30 Jul 2009 1.2 Final 01 Aug 2009 Equity shares
    11 Aug 2008 1.2 Final 13 Aug 2008 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    09 Jul 2026 24.0 Final 09 Jul 2026 Equity shares
    27 Jun 2025 4.0 Special 27 Jun 2025 Equity shares
    27 Jun 2025 20.0 Final 27 Jun 2025 Equity shares
    28 Jun 2024 16.0 Final 28 Jun 2024 Equity shares
    21 Jul 2023 12.0 Final 21 Jul 2023 Equity shares
    14 Jul 2022 9.6 Final 15 Jul 2022 Equity shares
    13 Aug 2021 7.2 Final 17 Aug 2021 Equity shares
    24 Mar 2020 4.0 Interim 26 Mar 2020 Equity shares
    22 Jul 2019 2.4 Final 24 Jul 2019 Equity shares
    19 Jul 2018 2.4 Final 21 Jul 2018 Equity shares
    13 Jul 2017 2.8 Final 17 Jul 2017 Equity shares
    22 Mar 2016 1.6 Interim 24 Mar 2016 Equity shares
    20 Jul 2015 0.8 Final 22 Jul 2015 Equity shares
    11 Sep 2014 0.8 Special 15 Sep 2014 Equity shares
    11 Sep 2014 1.2 Final 15 Sep 2014 Equity shares
    11 Jul 2013 1.2 Final 15 Jul 2013 Equity shares
    24 Jul 2012 0.8 Final 26 Jul 2012 Equity shares
    14 Jul 2011 1.6 Final 18 Jul 2011 Equity shares
    15 Jul 2010 1.44 Final 19 Jul 2010 Equity shares
    30 Jul 2009 1.2 Final 01 Aug 2009 Equity shares
    11 Aug 2008 1.2 Final 13 Aug 2008 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of RPG Life Sciences Ltd?

    Answer Field

    RPG Life Sciences Ltd share price is for NSE ₹ 2,450.00 & for BSE ₹ 2,430.00 as on Jul 06 2026 03:29 PM.

    What is the Market Cap of RPG Life Sciences Ltd Share?

    Answer Field

    The market cap of RPG Life Sciences Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 06 2026 03:29 PM.

    What is the 52 Week High and Low of RPG Life Sciences Ltd?

    Answer Field

    The 52 Week High and Low of RPG Life Sciences Ltd for NSE is ₹ 2,725.00 and ₹ 1,733.00 and for BSE is ₹ 2,715.90 and ₹ 1,731.25.

    What is 1 year return for RPG Life Sciences Ltd?

    Answer Field

    The 1 year returns on the stock has been 0.00%.

    What is the P/E Ratio of RPG Life Sciences Ltd Share?

    Answer Field

    As on Jul 06 2026 03:29 PM the price-to-earnings (PE) ratio for RPG Life Sciences Ltd share is 34.70.

    What is the PB ratio of RPG Life Sciences Ltd Share?

    Answer Field

    As on Jul 06 2026 03:29 PM, the price-to-book (PB) ratio for RPG Life Sciences Ltd share is 366.02.

    How to Buy RPG Life Sciences Ltd Share?

    Answer Field

    You can trade in RPG Life Sciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy RPG Life Sciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy RPG Life Sciences Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “RPG Life Sciences Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |